
    
      Study Objectives Primary To evaluate the average bioequivalence in healthy volunteers between
      medicinal product of Diclofenac Sodium 140mg Medicated Plaster EQI7 in comparison to the
      reference medicinal product Flector®, both formulated as topical plasters applied once and
      twice a day.

      Secondary To evaluate pharmacokinetic profile on Day 1, adhesivity, local tolerability and
      safety of medicinal product Diclofenac Sodium 140mg Medicated Plaster EQI7 in healthy
      volunteers in comparison to the reference medicinal product Flector®, both formulated as
      topical plasters applied once and twice a day.
    
  